"Race researchers have developed an improved & novel formulation of Zantrene
that enables peripheral intravenous (IV) delivery, expanding potential market"
Certainly an IV administration is easier
As it is a "novel" formulation any one know if safety trials etc etc will be required before any clinical trials?
"Race has signed a contract with Societal (San Diego, California, USA) to produce the new
RC220 IV formulation to the FDA current Good Manufacturing Practice (cGMP) standard
that is required for use in clinical trials."
FDA approval also needed
- Forums
- ASX - By Stock
- Ann: Race Develops Improved IV Formulation of Zantrene
"Race researchers have developed an improved & novel formulation...
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.000(0.00%) |
Mkt cap ! $239.6M |
Open | High | Low | Value | Volume |
$1.45 | $1.45 | $1.43 | $23.30K | 16.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 1105 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.440 |
2 | 100 | 1.435 |
1 | 7552 | 1.430 |
1 | 1135 | 1.425 |
3 | 1464 | 1.410 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 1105 | 3 |
1.455 | 192 | 2 |
1.460 | 169 | 1 |
1.485 | 8117 | 2 |
1.490 | 3500 | 1 |
Last trade - 11.13am 30/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.44 |
  |
Change
0.000 ( 0.79 %) |
|||
Open | High | Low | Volume | ||
$1.43 | $1.45 | $1.43 | 1167 | ||
Last updated 11.19am 30/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online